|
|
 Previous Article | Table of Contents | Next Article 
Blood, 15 October 2000, Vol. 96, No. 8, pp. 2735-2739
HEMATOPOIESIS
Protease inhibitors stimulate hematopoiesis and decrease
apoptosis and ICE expression in CD34+ cells
Elaine M. Sloand,
Jaroslaw Maciejewski,
Princy Kumar,
Sonnie Kim,
Aniruddho Chaudhuri, and
Neal Young
From the National Heart, Lung and Blood Institute,
National Institutes of Health, Bethesda, MD, and the Division of
Infectious Diseases, Georgetown University Medical Center,
Washington, DC.
Highly active retroviral therapy has been associated with a decline
in the frequency of cytopenia in patients with human immunodeficiency virus (HIV) infection. This may result from lower hematologic toxicity
of newer antiviral drugs and their increased efficacy against HIV-1.
Protease inhibitors, in addition to their effects on HIV replication,
appear to affect various cellular functions. Recently, it was
reported that ritonavir inhibited caspase-1 expression in
normal CD4+ cells. It was hypothesized that protease
inhibitors may improve hematopoietic function owing to their direct
effects on the bone marrow progenitor cells. When ritonavir was added
to methylcellulose cultures of bone marrow cells from HIV-infected
patients and normal controls, colony formation increased 2.4-fold
(n = 5) in control cultures and 4-fold (n = 5) in cultures of cells
from HIV-infected patients. In the presence of ritonavir, cultures of
CD34+ cells showed markedly decreased apoptosis in
comparison with untreated cultures (45% decrease in apoptotic cell
number; n = 6). A synthetic inhibitor of caspase 1 (Ac-Tyr-Val-Ala-Asp-aldehyde [single-letter amino acid codes]), which
inhibits activation of several caspases including CPP32 and interleukin
1 -converting enzyme (ICE or caspase 1), also
decreased the rate of apoptosis and enhanced colony formation by
progenitor cells derived from HIV-infected patients (3-fold; n = 5).
In ritonavir-treated samples derived from HIV-infected individuals, the
number of cells expressing ICE also decreased. In conclusion, HIV
protease inhibitors may, by blocking the caspase-dependent apoptotic
pathway, overcome inhibition of hematopoiesis seen in patients with HIV
infection, an effect unrelated to their antiviral activity.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
A. D. Redd, A. Avalos, and M. Essex
Infection of hematopoietic progenitor cells by HIV-1 subtype C, and its association with anemia in southern Africa
Blood,
November 1, 2007;
110(9):
3143 - 3149.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. M. Sloand, L. Pfannes, G. Chen, S. Shah, E. E. Solomou, J. Barrett, and N. S. Young
CD34 cells from patients with trisomy 8 myelodysplastic syndrome (MDS) express early apoptotic markers but avoid programmed cell death by up-regulation of antiapoptotic proteins
Blood,
March 15, 2007;
109(6):
2399 - 2405.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. T. Scadden, V. V. Muse, and R. P. Hasserjian
Case records of the Massachusetts General Hospital. Case 30-2006. A 41-year-old man with dyspnea, fever, and lymphadenopathy.
N. Engl. J. Med.,
September 28, 2006;
355(13):
1358 - 1368.
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. S. Koka, C. M. R. Kitchen, and S. T. Reddy
Targeting c-Mpl for Revival of Human Immunodeficiency Virus Type 1-Induced Hematopoietic Inhibition When CD34+ Progenitor Cells Are Re-Engrafted into a Fresh Stromal Microenvironment In Vivo
J. Virol.,
October 15, 2004;
78(20):
11385 - 11392.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Matarrese, L. Gambardella, A. Cassone, S. Vella, R. Cauda, and W. Malorni
Mitochondrial Membrane Hyperpolarization Hijacks Activated T Lymphocytes Toward the Apoptotic-Prone Phenotype: Homeostatic Mechanisms of HIV Protease Inhibitors
J. Immunol.,
June 15, 2003;
170(12):
6006 - 6015.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Estaquier, J.-D. Lelievre, F. Petit, T. Brunner, L. Moutouh-de Parseval, D. D. Richman, J. C. Ameisen, and J. Corbeil
Effects of Antiretroviral Drugs on Human Immunodeficiency Virus Type 1-Induced CD4+ T-Cell Death
J. Virol.,
May 13, 2002;
76(12):
5966 - 5973.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. N. Phenix, J. J. Lum, Z. Nie, J. Sanchez-Dardon, and A. D. Badley
Antiapoptotic mechanism of HIV protease inhibitors: preventing mitochondrial transmembrane potential loss
Blood,
August 15, 2001;
98(4):
1078 - 1085.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Chavan, S. Kodoth, R. Pahwa, and S. Pahwa
The HIV protease inhibitor Indinavir inhibits cell-cycle progression in vitro in lymphocytes of HIV-infected and uninfected individuals
Blood,
July 15, 2001;
98(2):
383 - 389.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. M. Levine, D. T. Scadden, J. A. Zaia, and A. Krishnan
Hematologic Aspects of HIV/AIDS
Hematology,
January 1, 2001;
2001(1):
463 - 478.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
